Clinical Trial Update: Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating carboplatin and paclitaxel with or without bevacizumab in newly diagnosed ovarian epithelial cancer, fallopian tube cancer, and prima…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Medical Research Council | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 3 | Status: COMPLETED